NASH Drugs Could Face Payer Roadblocks

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2Qe0Bhs on May 18, 2019 at 04:57PM While therapies for nonalcoholic steatohepatitis (NASH) aren’t expected to reach the market until a couple years yet, payers have already expressed some concerns about efficacy and price, BioPharma Dive reports. According to the report, the first drugs to hit the market […]

Tufts’ Chambers Highlights AMCP Presentation

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2wfvYz3 on May 18, 2019 at 04:57PM Tufts Medical Center’s James Chambers recently offered another look inside his presentation at the Academy of Managed Care Pharmacy’s (AMCP) March meeting in California. Chambers’ presentation in March highlighted patient input in specialty drug coverage decision making, as well as the […]

House OKs Bills on ACA, Drug Prices

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2JNrQxX on May 18, 2019 at 04:27PM The House this week pushed through a host of new health care bills aimed at supporting the Affordable Care Act and reducing prescription drug prices, the New York Times reports. Democrats, according to the report, had hoped tying prescription drug prices […]

Yale SOM celebrates Vahideh Manshadi on the benefits of scale in kidney exchange

from Market Design at http://bit.ly/2Jr9mEb on May 18, 2019 at 01:49PM In Yale Insights (from Yale SOM): Kidney Exchange Registries Should Collaborate to Save More LivesVAHIDEH MANSHADI "The results were surprising, says Manshadi. “We didn’t find any evidence that higher-frequency match runs were reducing the overall number of transplants by depleting the pool of potential […]